Cargando…
Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy
HE4 is a commonly used tumor marker for ovarian cancer (OC) diagnosis. In our study, we aimed to assess its use in the diagnosis of subsequent OC recurrences and to evaluate its changes during recurrence diagnosis and the subsequent lines of chemotherapy treatment. This retrospective single center s...
Autores principales: | Chudecka-Głaz, Anita, Strojna, Aleksandra, Michalczyk, Kaja, Wieder-Huszla, Sylwia, Safranow, Krzysztof, Skwirczyńska, Edyta, Jurczak, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913987/ https://www.ncbi.nlm.nih.gov/pubmed/36766556 http://dx.doi.org/10.3390/diagnostics13030452 |
Ejemplares similares
-
HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases
por: Chudecka-Głaz, Anita, et al.
Publicado: (2017) -
The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus
por: Jagodzińska, Anna, et al.
Publicado: (2023) -
Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021) -
The Significance of Adaptation and Coping with Disease among Patients with Diagnosed Gynaecological Cancer in the Context of Disease Acceptance
por: Wieder-Huszla, Sylwia, et al.
Publicado: (2022) -
Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?
por: Chudecka-Głaz, Anita, et al.
Publicado: (2018)